Ultrasound Assessment of Rectus Femoris Cross-sectionnal Area Following Lung Transplantation (EchoSS-TP)

H

Hopital Foch

Status

Not yet enrolling

Conditions

Lung Transplant
Physiotherapy
Sarcopenia

Treatments

Other: ultrasound measurement of the cross-sectional area of the rectus femoris

Study type

Observational

Funder types

Other

Identifiers

NCT06268171
2023_0214
2023-A02390-45 (Other Identifier)

Details and patient eligibility

About

In France, the profile of patients receiving lung transplants has changed in recent years, mainly due to the advent of treatment for cystic fibrosis. This progress has led to an evolution in the patient profile, with an increase in cases of pulmonary fibrosis or COPD, and an increase in the average age of patients. In these older patients, sarcopenia, a condition characterized by loss of muscle mass, is a major concern, as it exacerbates morbidity and mortality. After transplantation, patients are at risk of developing neuromyopathy due to their hospitalization in intensive care. There is currently no effective preventive treatment for this condition, underlining the need for early rehabilitation strategies. The combination of sarcopenia and neuromyopathy diminishes their functional capabilities on discharge from the ICU. Muscle ultrasound, a simple, non-invasive technique, is already used to assess muscle function in intensive care patients. This study aims to evaluate the use of ultrasound to measure muscle loss in lung transplant patients, in particular by examining the rectus femoris muscle. Objectives include observing variations in the surface area of the rectus femoris muscle before and after transplantation, identifying factors influencing this variation, and exploring its relationship with post-transplant morbidity. In summary, this study seeks to better understand muscle loss in lung transplant patients using ultrasound, in order to identify risk factors and guide the development of post-transplant rehabilitation strategies.

Enrollment

42 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient over the age of 18
  • Patient registered on the lung transplant list at Hôpital Foch for a single or double-lung transplant
  • Patient who did not object to inclusion in the study
  • Patient affiliated to a French health insurance plan

Exclusion criteria

  • Patient listed for a combined transplant (heart-lung, liver-lung, lung-kidney)
  • Patient on national priority list (super-emergency)
  • Pregnant or breast-feeding patient
  • Patient under guardianship

Trial design

42 participants in 1 patient group

Study group
Description:
transplant patients with ultrasound measurement of the cross-sectional area of the rectus femoris
Treatment:
Other: ultrasound measurement of the cross-sectional area of the rectus femoris

Trial contacts and locations

0

Loading...

Central trial contact

Elisabeth HULIER-AMMAR

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems